Analysts’ Viewpoint on Market Scenario
The foot and mouth disease vaccine market size is expected to increase at a steady pace in the next few years due to rise in number of foot and mouth disease (FMD) outbreaks. Increase in demand for livestock products is also projected to boost market expansion in the near future.
Rise in demand for animal protein, surge in government initiatives to control FMD outbreaks, and increase in awareness about animal health are propelling the demand for FMD vaccines. Animal protein is gaining traction among the populace due to changes in dietary habits and increase in disposable income.
FMD virus is highly contagious and outbreaks can cause significant economic losses due to restrictions on the movement of livestock and animal products. Thus, governments across the globe are focused on controlling FMD outbreaks. India and Brazil are implementing FMD control programs to prevent the spread of the disease.
Key players are developing advanced and effective FMD vaccines, including recombinant vaccines, virus-like particle vaccines, and synthetic peptide vaccines. They are also investing in improving the vaccine production process and expanding their distribution networks to broaden their customer base.
Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals, including cattle, pigs, sheep, goats, and deer. The disease causes significant economic losses due to decreased milk and meat production, death of infected animals, and trade restrictions. Vaccines are widely used to prevent the spread of FMD in countries where the disease is endemic or where there is a high risk of outbreaks.
The global foot and mouth disease vaccine industry includes both oil-based and aluminum hydroxide-based vaccines. Oil-based vaccines are more commonly used due to their longer-lasting immunity and fewer booster requirements.
Livestock products are gaining traction worldwide. The demand for animal products in emerging countries, such as India and Brazil, is expected to more than double by 2030. Thus, governments and vendors are seeking robust vaccines to prevent any FMD outbreaks that can affect livestock production.
Government initiatives play a vital role in the control and eradication of FMDs during an outbreak and during the time of routine vaccination. FMD-endemic countries and regions are constantly implementing various programs to control and eradicate the disease.
In 2019, the Food and Agriculture Organization (FAO) and the World Organization for Animal Health launched the Progressive Control Pathway for FMD (PCP-FMD). The program aims to help countries improve their FMD control measures, including the distribution of vaccines. The PCP-FMD provides a step-by-step approach for countries to progressively improve their FMD control measures, with the ultimate goal of achieving FMD-free status. Thus, implementation of various FMD control and eradication programs is expected to spur the foot and mouth disease vaccine market growth in the near future.
FMD is a highly contagious disease and spreads rapidly from one animal to another within a short time. Therefore, countries that are threatened by sudden outbreaks of viral infection are taking specific initiatives to control FMD outbreaks. They are investing significantly in routine vaccination to completely eradicate FMD from their respective regions. Such initiatives are driving the foot and mouth disease vaccine market value.
Several FMD outbreaks have occurred, worldwide, in the past few years, affecting livestock populations and causing economic losses. In May 2022, an outbreak of FMD was reported in cattle in Indonesia. It was the first outbreak since the country was declared FMD-free in 1986.
The Government of Indonesia launched a nationwide rollout of vaccinations in mid-June. It also restricted the movement of livestock and launched a campaign to educate farmers on the risks of FMD. Thus, repeated outbreaks of FMD cases in Asia Pacific and Middle East & Africa are augmenting the foot and mouth disease vaccine market trajectory.
According to the latest foot and mouth disease vaccine market trends, the oil-based vaccines type segment is expected to dominate the industry during the forecast period. Oil-based FMD vaccines provide long-term immunity against multiple FMD virus strains. These vaccines contain a killed virus that is emulsified in oil, which allows for a slow release of the virus and a longer duration of immunity.
Oil-based vaccines are more thermally stable than other types of FMD vaccines, which means they can withstand a wider range of temperatures during transport and storage without losing their potency. Additionally, these vaccines offer cross-protection against different FMD virus serotypes, meaning they can protect against multiple strains of the virus with a single vaccine. This is particularly important in regions where there are multiple circulating strains of FMD virus, as it can be difficult and expensive to produce individual vaccines for each strain. Oil-based vaccines are also considered safe and effective for use in pregnant animals, which is an important factor in maintaining a healthy livestock population.
According to the latest foot and mouth disease vaccine market analysis, the cattle animal segment is projected to hold major share from 2023 to 2031. FMD affects cloven-hoofed animals, including cattle, pigs, sheep, goats, and buffalo. However, cattle are particularly susceptible to FMD due to their high levels of viral replication and shedding. They also can remain asymptomatic carriers of the virus for extended periods of time.
Use of cattle for dairy and beef production is a significant contributor to the global economy. Outbreaks of FMD can have a significant impact on trade and exports, as several countries have stringent import regulations on animals and animal products from FMD-endemic countries. Therefore, there is a significant financial incentive for farmers, producers, and governments to invest in FMD vaccines for cattle.
According to the latest foot and mouth disease vaccine market research, the government institutions distribution channel segment is estimated to dominate the industry during the forecast period.
Government institutions are one of the major distribution channels for FMD vaccines due to several reasons. Firstly, FMD is a highly contagious viral disease that affects cloven-hoofed animals. This makes it a significant public health concern, and governments are often responsible for controlling and preventing its spread. Consequently, governments play a critical role in the distribution of FMD vaccines and are often the primary purchasers of vaccines for their livestock populations.
Secondly, government institutions have a wide network of distribution channels that allows them to reach a large number of livestock farmers and producers. Governments often have established veterinary departments and agencies that oversee the distribution and administration of vaccines to livestock populations. They also have the resources to develop and implement vaccination programs, which may include mass vaccination campaigns or targeted vaccination programs in areas where outbreaks are occurring.
According to the latest foot and mouth disease vaccine market forecast, Asia Pacific is anticipated to hold largest share from 2023 to 2031. The region accounted for the largest share in 2022. Presence of a large population of livestock and growth in the agriculture sector are fueling market dynamics in the region.
Several countries in Asia Pacific, such as China, India, and South Korea, have a well-established agricultural sector. Governments in these countries are actively implementing programs to control the spread of FMD, including vaccination campaigns. Rise in the export of livestock products is also driving market statistics in the region. China, India, and Hong Kong are one of the major exporters of beef and pork to the Americas and Europe.
Surge in investment in animal health programs, which include the development and use of FMD vaccines, is projected to augment market progress in Latin America during the forecast period. The Pan American Foot-and-Mouth Disease Center (PANAFTOSA) in Brazil has been at the forefront of FMD vaccine development and production in the region.
Implementation of various regulations and vaccination programs to control and eradicate FMD, with support from the World Organization for Animal Health (OIE), is also boosting the market revenue in Latin America.
Rise in outbreaks of FMD is likely to fuel the foot and mouth disease vaccine market share of Middle East & Africa in the near future. FMD is endemic in many parts of the region, with frequent outbreaks occurring due to various factors such as the presence of multiple FMD virus serotypes, inadequate biosecurity measures, and movement of animals across borders. These outbreaks can lead to significant economic losses, making FMD vaccination a priority for governments and farmers in Middle East & Africa.
The global industry is fragmented, with the presence of several foot and mouth disease vaccine manufacturers including BVI, Indian Immunologicals Ltd, Ceva Santé Animale, MEVAC, National Veterinary Institute, Limor de Colombia SAS, Brilliant Bio Pharma, VETAL Animal Health Products, Inc., Biogénesis Bagó, Kenya Veterinary Vaccines Production Institute, Boehringer Ingelheim International GmbH, Zoetis, Inc., and Ourofino Saúde Animal.
Key players in the foot and mouth disease vaccine market report have been profiled based on various parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|---|---|
|
Market Size in 2022 |
US$ 1.4 Bn |
|
Market Forecast Value in 2031 |
More than US$ 2.4 Bn |
|
CAGR |
5.9% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
The global market was valued at US$ 1.4 Bn in 2022
It is projected to surpass a value of US$ 2.4 Bn by the end of 2031
It is anticipated to be 5.9% from 2023 to 2031
The oil-based vaccines type segment held more than 60.0% share in 2022
Asia Pacific is expected to record highest demand from 2023 to 2031
BVI, Indian Immunologicals Ltd, Ceva Santé Animale, MEVAC, National Veterinary Institute, Limor de Colombia SAS, Brilliant Bio Pharma, VETAL Animal Health Products, Inc., Biogénesis Bagó, Kenya Veterinary Vaccines Production Institute, Boehringer Ingelheim International GmbH, Zoetis, Inc., and Ourofino Saúde Animal
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Foot and Mouth Disease Vaccine Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Foot and Mouth Disease Overview
5.2. Disease Prevalence & Incidence Rate Overview
5.3. Regulatory Scenario
5.4. Key Industry Events
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Aluminum Hydroxide and Saponin Vaccines
6.3.2. Oil-based Vaccines
6.3.2.1. Single-oil Emulsion
6.3.2.2. Double-oil Emulsion
6.4. Market Attractiveness, by Type
7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Animal, 2017-2031
7.3.1. Cattle
7.3.2. Sheep and Goat
7.3.3. Swine/Pig
7.3.4. Others
7.4. Market Attractiveness, by Animal
8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2017-2031
8.3.1. Veterinary Clinics
8.3.2. Government Institutions
8.3.3. Others
8.4. Market Attractiveness, by Distribution Channel
9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. Asia Pacific
9.2.2. Latin America
9.2.3. Middle East & Africa
9.2.4. Rest of the World
9.3. Market Attractiveness, by Country/Region
10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. Aluminum Hydroxide and Saponin Vaccines
10.2.2. Oil-based Vaccines
10.2.2.1. Single-oil Emulsion
10.2.2.2. Double-oil Emulsion
10.3. Market Value Forecast, by Animal, 2017-2031
10.3.1. Cattle
10.3.2. Sheep and Goat
10.3.3. Swine/Pig
10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017-2031
10.4.1. Veterinary Clinics
10.4.2. Government Institutions
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
10.5.1. China
10.5.2. India
10.5.3. Rest of Asia Pacific
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Animal
10.6.3. By Distribution Channel
10.6.4. By Country/Sub-region
11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. Aluminum Hydroxide and Saponin Vaccines
11.2.2. Oil-based Vaccines
11.2.2.1. Single-oil Emulsion
11.2.2.2. Double-oil Emulsion
11.3. Market Value Forecast, by Animal, 2017-2031
11.3.1. Cattle
11.3.2. Sheep and Goat
11.3.3. Swine/Pig
11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017-2031
11.4.1. Veterinary Clinics
11.4.2. Government Institutions
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Brazil
11.5.2. Argentina
11.5.3. Rest of Latin America
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Animal
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Aluminum Hydroxide and Saponin Vaccines
12.2.2. Oil-based Vaccines
12.2.2.1. Single-oil Emulsion
12.2.2.2. Double-oil Emulsion
12.3. Market Value Forecast, by Animal, 2017-2031
12.3.1. Cattle
12.3.2. Sheep and Goat
12.3.3. Swine/Pig
12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017-2031
12.4.1. Veterinary Clinics
12.4.2. Government Institutions
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. GCC Countries
12.5.2. South Africa
12.5.3. Rest of Middle East & Africa
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Animal
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Aluminum Hydroxide and Saponin Vaccines
13.2.2. Oil-based Vaccines
13.2.2.1. Single-oil Emulsion
13.2.2.2. Double-oil Emulsion
13.3. Market Value Forecast, by Animal, 2017-2031
13.3.1. Cattle
13.3.2. Sheep and Goat
13.3.3. Swine/Pig
13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017-2031
13.4.1. Veterinary Clinics
13.4.2. Government Institutions
13.4.3. Others
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By Animal
13.5.3. By Distribution Channel
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles
14.2.1. BVI
14.2.1.1. Company Overview
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. Business Strategies
14.2.1.5. Recent Developments
14.2.2. Indian Immunologicals Ltd.
14.2.2.1. Company Overview
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. Business Strategies
14.2.2.5. Recent Developments
14.2.3. Ceva Santé Animale
14.2.3.1. Company Overview
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. Business Strategies
14.2.3.5. Recent Developments
14.2.4. MEVAC
14.2.4.1. Company Overview
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. Business Strategies
14.2.4.5. Recent Developments
14.2.5. National Veterinary Institute
14.2.5.1. Company Overview
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. Business Strategies
14.2.5.5. Recent Developments
14.2.6. Limor de Colombia SAS
14.2.6.1. Company Overview
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. Business Strategies
14.2.6.5. Recent Developments
14.2.7. Brilliant Bio Pharma
14.2.7.1. Company Overview
14.2.7.2. Financial Overview
14.2.7.3. Product Portfolio
14.2.7.4. Business Strategies
14.2.7.5. Recent Developments
14.2.8. VETAL Animal Health Products, Inc.
14.2.8.1. Company Overview
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. Business Strategies
14.2.8.5. Recent Developments
14.2.9. Biogénesis Bagó
14.2.9.1. Company Overview
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. Business Strategies
14.2.9.5. Recent Developments
14.2.10. Kenya Veterinary Vaccines Production Institute
14.2.10.1. Company Overview
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. Business Strategies
14.2.10.5. Recent Developments
14.2.11. Boehringer Ingelheim International GmbH
14.2.11.1. Company Overview
14.2.11.2. Financial Overview
14.2.11.3. Product Portfolio
14.2.11.4. Business Strategies
14.2.11.5. Recent Developments
14.2.12. Zoetis, Inc.
14.2.12.1. Company Overview
14.2.12.2. Financial Overview
14.2.12.3. Product Portfolio
14.2.12.4. Business Strategies
14.2.12.5. Recent Developments
14.2.13. Ourofino Saúde Animal
14.2.13.1. Company Overview
14.2.13.2. Financial Overview
14.2.13.3. Product Portfolio
14.2.13.4. Business Strategies
14.2.13.5. Recent Developments
List of Tables
Table 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 02: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
Table 03: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
Table 04: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 05: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Region, 2017-2031
Table 06: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 07: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
Table 08: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
Table 09: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 10: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 12: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
Table 13: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
Table 14: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 15: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 17: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
Table 18: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
Table 19: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 20: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 21: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 22: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
Table 23: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
Table 24: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
List of Figures
Figure 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
Figure 02: Foot and Mouth Disease Vaccine Market Value Share, by Type, 2022
Figure 03: Foot and Mouth Disease Vaccine Market Value Share, by Animal, 2022
Figure 04: Foot and Mouth Disease Vaccine Market Value Share, by Distribution Channel, 2022
Figure 05: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
Figure 06: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
Figure 07: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Aluminum Hydroxide and Saponin Vaccines, 2017‒2031
Figure 08: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Oil-based Vaccines, 2017‒2031
Figure 09: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
Figure 10: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
Figure 11: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Cattle, 2017-2031
Figure 12: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Sheep and Goat, 2017-2031
Figure 13: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Swine/Pig, 2017-2031
Figure 14: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
Figure 15: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 16: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 17: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Veterinary Clinics, 2017-2031
Figure 18: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Government Institutions, 2017-2031
Figure 19: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
Figure 20: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
Figure 23: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
Figure 24: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
Figure 25: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
Figure 26: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
Figure 27: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 28: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 29: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 31: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
Figure 32: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
Figure 33: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
Figure 34: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
Figure 35: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
Figure 36: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 37: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 38: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 40: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
Figure 41: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
Figure 42: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
Figure 43: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
Figure 44: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
Figure 45: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 46: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 47: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 49: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
Figure 50: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
Figure 51: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
Figure 52: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
Figure 53: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
Figure 54: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 55: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Foot and Mouth Disease Vaccine Market
